CG MedTech Co

CG MedTech Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of CG MedTech Co (056090.KQ) as of Nov 20, 2026 is -143.33 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 1,173.87 % — a change of -112.21% (lower).

FCF Conversion

-143.33 %

YoY

-112.21%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of CG MedTech Co is 2025 -143.33 % . FCF Conversion Rate (FCF/EBITDA) of CG MedTech Co was 2024 1,173.87 % . It decreases by -112.21% lower compared to the previous year.

The CG MedTech Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
124.48 KRW
Jan 1, 2019
149.33 KRW
Jan 1, 2020
-15.84 KRW
Jan 1, 2021
-8.50 KRW
Jan 1, 2022
34.06 KRW
Jan 1, 2023
-253.12 KRW
Jan 1, 2024
1,173.87 KRW
Jan 1, 2025
-143.33 KRW
The CG MedTech Co FCF Conversion history
YEARFCF ConversionYoY
-143.33 %-112.21%
1,173.87 %-563.77%
-253.12 %-843.15%
34.06 %-500.66%
-8.50 %-46.32%
-15.84 %-110.61%
149.33 %+19.97%
124.48 %+250.43%
35.52 %-83.78%
218.94 %-70.38%
739.21 %+1,822.93%
38.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

FCF Conversion Rate (FCF/EBITDA) of CG MedTech Co is -143.33 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of CG MedTech Co changed from 1,173.87 % to -143.33 %, representing a -112.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s CG MedTech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — CG MedTech Co

All Key Metrics — CG MedTech Co